What are the effects of semaglutide for weight loss?
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Effects of Semaglutide for Weight Loss
Introduction to Semaglutide and Weight Loss
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising pharmacological option for weight loss in individuals with obesity or overweight, particularly those without diabetes. This article synthesizes findings from multiple studies to provide a comprehensive overview of the efficacy and safety of semaglutide for weight loss.
Efficacy of Semaglutide in Weight Reduction
Significant Weight Loss Outcomes
Semaglutide has demonstrated substantial efficacy in promoting weight loss among obese or overweight individuals. In a systematic review and meta-analysis, semaglutide was associated with a significant reduction in body weight, body mass index (BMI), and waist circumference compared to placebo . Specifically, semaglutide induced a mean body weight loss of approximately 10-15% over 68 weeks, with a higher proportion of participants achieving weight reductions of 5%, 10%, 15%, and even 20% .
Dose-Dependent Effects
The weight loss effects of semaglutide are dose-dependent. Higher doses, such as 2.4 mg administered once weekly, have been shown to produce more pronounced weight loss compared to lower doses or other GLP-1 receptor agonists like liraglutide . For instance, semaglutide 2.4 mg resulted in a mean weight loss of 12.47 kg, significantly outperforming liraglutide 3.0 mg, which achieved a mean weight loss of 5.24 kg.
Safety and Tolerability of Semaglutide
Common Adverse Effects
While semaglutide is effective for weight loss, it is also associated with some adverse effects, primarily gastrointestinal in nature. Nausea, diarrhea, and other gastrointestinal symptoms are the most commonly reported side effects, though they are typically mild to moderate and tend to subside over time .
Serious Adverse Events
The incidence of serious adverse events is relatively low. However, some studies have reported a higher frequency of gastrointestinal adverse events leading to treatment discontinuation in the semaglutide group compared to placebo . Additionally, there have been isolated reports of cholelithiasis (gallstones) and hypoglycemia, particularly in the absence of lifestyle interventions .
Additional Health Benefits
Cardiometabolic Improvements
Beyond weight loss, semaglutide has shown beneficial effects on various cardiometabolic risk factors. These include improvements in blood pressure, lipid profiles, and C-reactive protein levels, which are markers of inflammation . These additional benefits make semaglutide a valuable option for comprehensive obesity management.
Impact on Physical Functioning
Participants receiving semaglutide also reported greater improvements in physical functioning and overall quality of life compared to those receiving placebo. This suggests that the benefits of semaglutide extend beyond mere weight reduction, contributing to enhanced physical and possibly psychological well-being.
Conclusion
Semaglutide is a highly effective and generally well-tolerated option for weight loss in obese or overweight individuals without diabetes. Its significant impact on body weight, coupled with improvements in cardiometabolic health, makes it a compelling choice for long-term obesity management. However, potential gastrointestinal side effects and the need for careful monitoring of adverse events should be considered in clinical practice.
Sources and full results
Most relevant research papers on this topic
Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
Abstract 15741: Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Individuals With Obesity or Overweight but Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial.
Once-Weekly Semaglutide in Adolescents with Obesity.
Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Semaglutide lowers body weight in rodents via distributed neural pathways.
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review
Try another search
What are the effects of global warming on infectious disease patterns?
What are the implications of scientific revolutions for the philosophy of science?
What are the best practices for ensuring healthy aging and longevity?
What are the health impacts of air pollution?
What are the implications of recent research on the optimal balance of macronutrients for health and performance?
Philosophy of Science: